El cruce duodenal (Roux DS) explicado: la cirugía bariátrica más potente comparada con el SADI-S y el bypass

Hello, and thank you for taking the time to learn about the biliopancreatic diversion with duodenal switch — often just called the duodenal switch, or the Roux DS. If you are watching this, you or someone you care about may be considering weight-loss surgery, and my goal is to give you a clear, honest, data-driven understanding of this operation.

The Roux DS is the most powerful metabolic and bariatric surgery available. It produces the greatest weight loss and the highest rates of diabetes remission of any standard procedure. It has been performed since the late 1990s and has more than two decades of long-term data behind it.

It is also the most complex bariatric operation and the one that demands the most from you afterward. It requires the most intensive nutritional monitoring, the most rigorous vitamin supplementation, and the most consistent follow-up of any procedure.

If you have watched our video on the SADI-S — the single anastomosis duodenal switch — you already know that the SADI-S was designed as a simplification of this operation. Throughout this video, I will compare the two directly so you can understand exactly where they overlap and where they diverge. I will also compare the Roux DS to the Roux-en-Y gastric bypass, because for patients with very high BMI, the choice between these two operations is one of the most important decisions in bariatric surgery.

Let us get into it.

Who Qualifies?

Current ASMBS guidelines recommend metabolic surgery for BMI 35 or higher regardless of other conditions, BMI 30 to 35 with metabolic disease like diabetes or sleep apnea, and for patients of Asian descent, generally 27.5 or above.

The Roux DS is especially well suited for patients with very high BMI — 50 or above — where simpler procedures may not produce enough weight loss. A randomized controlled trial with 15-year follow-up showed that the Roux DS produced 37.5 percent total weight loss versus 22.8 percent for gastric bypass in super-obese patients. That is a 65 percent greater weight loss — a difference that persisted for 15 years.

It is also an excellent option for patients with severe, insulin-dependent type 2 diabetes, and for patients who have had weight regain after a prior sleeve gastrectomy.

The Procedure: How the Roux DS Differs from the SADI-S

Both operations start the same way. We perform a sleeve gastrectomy, removing about 75 to 85 percent of the stomach including the fundus. The pylorus is preserved. Then we divide the duodenum about two to three centimeters below the pylorus.

This is where the two operations diverge. In the SADI-S, we bring a single loop of ileum up and connect it directly to the divided duodenum. One connection. One anastomosis. The common channel is 250 to 300 centimeters.

In the Roux DS, we do something more complex. We divide the small intestine and rearrange it into three separate channels connected by two intestinal connections.

First, we measure from the ileocecal valve and mark the common channel — typically 100 to 150 centimeters. This is the only segment where food and digestive juices will mix and nutrients will be absorbed. Then we measure an additional 150 to 200 centimeters upstream — that becomes the alimentary limb, the channel that carries food. We connect the alimentary limb to the divided duodenum — the duodenoileostomy. Then we reconnect the biliopancreatic limb — which carries bile and pancreatic enzymes — downstream at the start of the common channel — the ileoileostomy.

After surgery, food travels from the sleeve through the pylorus, down the alimentary limb, and into the common channel. Bile and digestive enzymes travel separately through the biliopancreatic limb and only meet the food in the common channel — the last 100 to 150 centimeters.

The critical difference: the Roux DS has a shorter common channel than the SADI-S — 100 to 150 centimeters versus 250 to 300. That means more malabsorption, more weight loss potential, but also more nutritional risk. It also has two intestinal connections instead of one, which means a longer operative time — typically 90 to 150 minutes versus 60 to 120 for the SADI-S — and more mesenteric defects to close.

But the Roux-en-Y configuration has one major advantage: it completely eliminates bile reflux. Because the alimentary limb and the biliopancreatic limb are separate channels that only meet downstream, bile cannot travel backward into the duodenal stump or the sleeve. In the SADI-S, which uses a loop configuration, bile reflux is clinically significant in 1 to 7.5 percent of patients. In the Roux DS, it is zero.

Most patients stay one to three nights in the hospital and return to normal activities within two to four weeks.

How It Works

The Roux DS works through the same core mechanisms as the SADI-S — restriction, hormonal reprogramming, and malabsorption — but with a more aggressive malabsorptive component.

The sleeve limits how much you can eat. Removing the fundus dramatically reduces ghrelin — the hunger hormone. Bypassing most of the small intestine delivers food rapidly to the distal gut, triggering a massive surge in GLP-1 and PYY — hormones that tell your brain you are full and that improve insulin secretion and sensitivity. Studies show GLP-1 levels increase by 260 to 330 percent after the duodenal switch — more pronounced than after any other bariatric procedure.

The key physiological difference from the SADI-S is the degree of malabsorption. Because the common channel is shorter — 100 to 150 centimeters versus 250 to 300 — the body absorbs significantly fewer calories, less fat, and fewer micronutrients. This is why the Roux DS produces the most weight loss but also carries the highest nutritional risk.

The pylorus is preserved in both operations, which controls gastric emptying and is why dumping syndrome is uncommon after either procedure — a significant advantage over Roux-en-Y gastric bypass, where dumping affects 36 to 50 percent of patients.

Results: Weight Loss and Health Improvements

The Roux DS produces the greatest and most durable weight loss of any bariatric procedure.

Patients typically lose 35 to 40 percent of total body weight, or 65 to 80 percent of excess weight. A study with up to 20 years of follow-up showed excess BMI loss of 78 percent at 5 years, 76.5 percent at 10 years, and 77.8 percent at 14 years — remarkably stable. A 10-year study reported 40.7 percent total weight loss maintained at over a decade.

How does this compare? In the 15-year randomized trial against gastric bypass in super-obese patients, the Roux DS produced 37.5 percent total weight loss versus 22.8 percent — a difference that was statistically significant and clinically enormous. Against the SADI-S, a 10-year multicenter study found maximum total weight loss was essentially identical — 45.7 percent for the Roux DS versus 47.3 percent for the SADI-S. Beyond 5 years, some series suggest the Roux DS may maintain slightly better weight loss, though the differences are modest.

Health improvements are dramatic. Type 2 diabetes remission ranges from 85 to 93 percent — the highest of any procedure. Even in patients on insulin, 68 percent achieved complete remission at 10 years. A meta-analysis found the SADI-S achieved comparable diabetes remission. Both duodenal switch procedures significantly outperform gastric bypass for diabetes, which achieves long-term complete remission in 30 to 54 percent.

Hypertension improves in 54 to 81 percent. Dyslipidemia remission is exceptional — 77 to 95 percent. Sleep apnea resolves in 82 to 100 percent. These improvements translate into approximately a 50 percent reduction in all-cause mortality and a median life expectancy gain of about 6 years.

Some weight regain after reaching your lowest weight is normal. About 61 percent of patients regain more than 10 percent of the weight they initially lost by 10 years. However, even with that regain, 78 percent maintain a BMI below 35, and excess weight loss remains in the 70 to 78 percent range at 10 to 14 years — better than any other operation.

Risks and Complications: Where the Roux DS Differs Most

The Roux DS is safe when performed by experienced surgeons at high-volume centers. Mortality is approximately 0.1 to 0.4 percent. A national database study of nearly 22,000 patients found a leak rate of 0.8 percent. The 30-day complication rate is approximately 8 to 12 percent.

But the long-term complication profile is where the Roux DS differs most from the SADI-S — and this is what you need to understand.

Nutritional deficiencies are the most important long-term concern — and this is the biggest difference between the two operations. In the 10-year multicenter comparative study, nutritional complications occurred in 53.5 percent of Roux DS patients versus 15.6 percent of SADI-S patients. That is a dramatic difference. The shorter common channel in the Roux DS means less absorption of everything — not just calories, but vitamins, minerals, and protein.

Specific deficiency rates after the Roux DS: vitamin D deficiency in up to 100 percent without supplementation. Vitamin A deficiency in up to 70 percent within 4 years. Zinc deficiency in up to 70 percent. Copper deficiency in up to 90 percent. Iron deficiency is common, especially in premenopausal women. Protein malnutrition — the most serious nutritional complication — occurs in 3 to 11 percent and may require hospitalization or surgical revision to lengthen the common channel.

Diarrhea and loose stools are significantly more common than after the SADI-S. In a comparative study of transit bipartition versus Roux DS, 33 percent of Roux DS patients reported more than three stools per day, compared to 7 percent with the bipartition approach. Surgical reintervention for malnutrition or side effects was needed in 10 percent of Roux DS patients versus 4 percent with bipartition.

Reoperation rates are higher than other procedures — 14 to 42 percent in long-term studies — for malnutrition, diarrhea, reflux, and hernias. Bile reflux: zero. This is the single biggest advantage of the Roux configuration over the SADI-S loop configuration. If bile reflux is a concern — or if a patient has had bile reflux after a SADI-S — conversion to the Roux DS eliminates it entirely.

De novo GERD has been reported in up to 44 percent in some long-term series, though this is related to the sleeve component rather than the intestinal rerouting. Marginal ulcers are uncommon — about 2 to 4 percent — because the pylorus is preserved. This is a major advantage over gastric bypass, where marginal ulcers occur in 10 to 16 percent.

Dumping syndrome is uncommon because the pylorus is intact — another advantage over gastric bypass.

The Bottom Line: Roux DS Versus SADI-S Versus RYGB

These three operations serve different patients. The differences are in the details. Roux DS advantages over SADI-S: eliminates bile reflux entirely, may have a slight edge in very long-term weight maintenance beyond 5 years, longest track record with 20-plus years of data. SADI-S advantages over Roux DS: dramatically fewer nutritional complications (15.6% vs 53.5% at 10 years), shorter operative time, simpler technique, one fewer anastomosis, one fewer mesenteric defect, comparable weight loss and diabetes remission.

Roux DS advantages over RYGB: significantly greater weight loss (37.5% vs 22.8% TWL at 15 years in super-obese patients), higher diabetes remission, fewer marginal ulcers, less dumping syndrome. RYGB advantages over Roux DS: simpler operation, fewer nutritional complications, lower reoperation rate, better reflux control (97% improvement), 30-plus years of data.

If you have very high BMI and need maximum weight loss, the Roux DS or SADI-S is the right choice. If bile reflux is a concern or you want the longest track record, the Roux DS has the advantage. If you want comparable metabolic power with fewer nutritional complications, the SADI-S is the better fit. If your BMI is lower or nutritional compliance is a concern, gastric bypass may be the safer choice.

Life After Surgery

Life after the Roux DS requires the most commitment of any bariatric procedure. Protein first — at least 80 to 100 grams per day. Diet progresses in stages from liquids to solids over six to eight weeks.

Vitamins are lifelong and non-negotiable. You will need a bariatric multivitamin with fat-soluble vitamins in dry or water-soluble form, calcium citrate at 1,800 to 2,400 milligrams per day, high-dose vitamin D often 50,000 IU or more per week, vitamin A often 10,000 IU or more per day, iron at 45 to 65 milligrams per day, zinc, B12, and copper — all monitored and supplemented as needed.

Blood work every 3 to 6 months in the first year, then at least annually for life. If you stop taking your vitamins or stop coming to follow-up, you are at risk for serious and sometimes irreversible nutritional complications. This is the single most important commitment you make after this surgery.

Build to at least 150 minutes of exercise per week. Over 82 percent of patients in long-term studies say they would choose the procedure again.

Final Thoughts

The Roux DS is the most powerful metabolic operation we have. It produces the greatest weight loss, the highest diabetes remission, and the most dramatic improvements in metabolic disease. It eliminates bile reflux entirely — something the SADI-S cannot do. And it has the longest track record of any duodenal switch procedure.

But it demands the most from you in return — lifelong vitamins, lifelong labs, lifelong follow-up. The nutritional complication rate is real, and it is significantly higher than the SADI-S.

If you are considering this surgery, the next step is a consultation. We will look at your individual situation — your BMI, your health conditions, your prior surgeries, your goals — and help you decide whether the Roux DS, the SADI-S, or another procedure is the right fit. You deserve a life that feels bigger than your weight, and we are here to help you get there.

Real science. Real surgery. Real results

Thank you for watching.\